Glycaemic control
At baseline, there was no significant difference between the groups’ levels of glycated haemoglobin (HbA1c). The HbA1c level decreased from 7.9 ± 0.3% to 7.4 ± 0.2% in the test group and from 8.2 ± 0.3% to 7.5 ± 0.2% in the control group. However, the comparison between the groups showed no statistically significant difference after 3 months. Figure The level of HbA1c in the test and the control groups at baseline and after 3 months